Literature DB >> 15981102

Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1.

Chunlan Sun1, Takashi Yamato, Emiko Kondo, Toru Furukawa, Hidetoshi Ikeda, Akira Horii.   

Abstract

We analyzed mutation of the APC, AXIN1, and GSK3genes in 14 pituitary adenomas with abnormal nuclear accumulations of CTNNB1. These tumors did not harbor mutation of the CTNNB1 gene. The genes analyzed encode proteins associated with ubiquitin-mediated degradation of CTNNB1. Although the regions encoding functional domains of these protein products were analyzed, no significant genetic alterations were found. Furthermore, the antibody for the C-terminus of APC detected normal expression of the APC protein in these pituitary adenomas. Our present results imply that an unknown mechanism(s) accelerates the accumulation of CTNNB1 that plays an important role in the pathogenesis of human pituitary adenomas. However, the possibility that mutation of regions outside of our survey or epigenetic mechanism play an important role cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981102     DOI: 10.1007/s11060-004-4597-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation.

Authors:  M Woloschak; A Yu; K D Post
Journal:  Mol Carcinog       Date:  1997-08       Impact factor: 4.784

3.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

Authors:  O Tetsu; F McCormick
Journal:  Nature       Date:  1999-04-01       Impact factor: 49.962

4.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

5.  Frequent nuclear accumulation of beta-catenin in pituitary adenoma.

Authors:  S Semba; S Y Han; H Ikeda; A Horii
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

6.  Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.

Authors:  A B Sparks; P J Morin; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

7.  Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.

Authors:  C O Evans; M R Brown; J S Parks; N M Oyesiku
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

9.  The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer.

Authors:  A Horii; S Nakatsuru; Y Miyoshi; S Ichii; H Nagase; Y Kato; A Yanagisawa; Y Nakamura
Journal:  Cancer Res       Date:  1992-06-01       Impact factor: 12.701

10.  Nuclear translocation of beta-catenin in colorectal cancer.

Authors:  M Kobayashi; T Honma; Y Matsuda; Y Suzuki; R Narisawa; Y Ajioka; H Asakura
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  5 in total

1.  Expression and clinical significance of Wnt players and survivin in pituitary tumours.

Authors:  Robert Formosa; Mark Gruppetta; Sharon Falzon; Graziella Santillo; James DeGaetano; Angela Xuereb-Anastasi; Josanne Vassallo
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

Review 2.  Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis.

Authors:  Maria Gueorguiev; Ashley B Grossman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

3.  Discovery of transcriptional regulators and signaling pathways in the developing pituitary gland by bioinformatic and genomic approaches.

Authors:  Michelle L Brinkmeier; Shannon W Davis; Piero Carninci; James W MacDonald; Jun Kawai; Debashis Ghosh; Yoshihide Hayashizaki; Robert H Lyons; Sally A Camper
Journal:  Genomics       Date:  2009-02-11       Impact factor: 5.736

4.  Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression.

Authors:  Gianina Demarchi; Sofía Perrone; Gaela Esper Romero; Cristian De Bonis; Juan Pablo Casasco; Gustavo Sevlever; Silvia Ines Berner; Carolina Cristina
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

5.  Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors.

Authors:  Leandro Machado Colli; Fabiano Saggioro; Luciano Neder Serafini; Renata Costa Camargo; Helio Rubens Machado; Ayrton Custodio Moreira; Sonir R Antonini; Margaret de Castro
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.